Corvari, V., Narhi, L. O., Spitznagel, T. M., Afonina, N., Cao, S., Cash, P., Cecchini, I., DeFelippis, M. R., Garidel, P., Herre, A., Koulov, A. V., Lubiniecki, T., Mahler, H., Mangiagalli, P., Nesta, D., Perez-Ramirez, B., Polozova, A., Rossi, M., Schmidt, R., Simler, R., Singh, S., Weiskopf, A., & Wuchner, K. (n.d.). subvisible (2–100 μm) particle analysis during biotherapeutic drug product development: Part 2, experience with the application of subvisible particle analysis. Biologicals, 43(6), 457–473. http://access.bl.uk/ark:/81055/vdc_100029477736.0x000007